Core Viewpoint - CardioComm Solutions, Inc. has terminated a royalty agreement and entered into a $512,000 loan facility to advance its GEMS FLEX and 14-day Holter/LTCM ECG software platform, which is expected to be a major revenue source for the company [2][3]. Group 1: Loan Agreement Details - The Loan Agreement provides new working capital to complete and commercialize the GEMS FLEX and 14-day Holter and Event long-term continuous monitoring ECG software platform [3]. - Key terms of the Loan Agreement include finalizing the flagship product for market release, conducting user feedback reviews, launching and marketing the product, and providing post-launch support [6]. - The loan consists of $350,000 from Xemxija Holdings Inc., $80,000 from Etienne Grima, and $82,000 from ITF Ventures Inc. [7]. Group 2: Royalty Agreement Termination - The Royalty Agreement was terminated due to additional review requirements from the TSX Venture Exchange, which would delay capital access [4]. - A copy of the terminated Royalty Agreement has been filed on SEDAR+ as part of compliance with the Ontario Securities Commission [4]. Group 3: Related Party Transactions - The loans under the Loan Agreement and the issuance of Bonus Shares and Bonus Warrants are classified as related party transactions under Multilateral Instrument 61-101 [11]. - The Loan Transaction is exempt from formal valuation and minority shareholder approval requirements due to the terms being reasonable and not less advantageous than market terms [11]. - The Bonus Transaction is also exempt from minority shareholder approval as its value does not exceed 25% of the company's market capitalization [11].